| P50 | author | Tania Incitti | Q39692804 |
| | Tiziana Santini | Q61124861 |
| P2093 | author name string | Davide Cacchiarelli | |
| | Marcella Cesana | |
| | Irene Bozzoni | |
| | Olga Sthandier | |
| | Valentina Cazzella | |
| | Julie Martone | |
| P2860 | cites work | The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 |
| | Distinctive patterns of microRNA expression in primary muscular disorders | Q24675407 |
| | Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping | Q28291830 |
| | The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation | Q28298317 |
| | Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide | Q33991414 |
| | Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells | Q34035676 |
| | miR-31: a crucial overseer of tumor metastasis and other emerging roles | Q34117603 |
| | Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides | Q34470860 |
| | Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. | Q34574529 |
| | Toward microRNA-based therapeutics for heart disease: the sense in antisense | Q34599246 |
| | Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia | Q34986949 |
| | Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy | Q36534906 |
| | The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 |
| | miRNA in situ hybridization in formaldehyde and EDC-fixed tissues | Q39612232 |
| | Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping | Q39692533 |
| | Stable knockdown of microRNA in vivo by lentiviral vectors | Q39910684 |
| | A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells | Q44992027 |
| | Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides | Q45007187 |
| | Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice. | Q45394829 |
| | Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology | Q46917397 |
| | The regulatory mechanisms that underlie inappropriate transcription of the myogenic determination gene Myf5 in the central nervous system. | Q51944202 |
| | Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. | Q54781099 |
| | MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway | Q62722983 |
| | Local dystrophin restoration with antisense oligonucleotide PRO051 | Q80412961 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| P304 | page(s) | 136-141 | |
| P577 | publication date | 2011-01-07 | |
| P1433 | published in | EMBO Reports | Q5323356 |
| P1476 | title | miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy | |
| P478 | volume | 12 | |